Log In|Sign Up
ENLipodystrophy, Congenital Generalized, Type 1 (CGL1)
Alias:
Congenital Generalized Lipodystrophy Type 1
Berardinelli-Seip Congenital Lipodystrophy, Type 1
Lipodystrophy, Berardinelli-Seip Congenital, Type 1
Brunzell Syndrome, Agpat2-Related
Brunzell Syndrome Agpat2-Related
Bscl1
Cgl1
Berardinelli-Seip Congenital Lipodystrophy Type 1
Total Lipodystrophy and Acromegaloid Gigantism
Lipodystrophy, Generalized, Congenital, Type 1
Congenital Generalized Lipodystrophy 1
Familial Partial Lipodystrophy, Type 2
Familial Generalized Lipodystrophy
Lipodystrophy Berardinelli Type
Lipoatrophic Diabetes Mellitus
Berardinelli-Seip Syndrome
Lipoatrophic Diabetes
Favorite
Lipodystrophy, Congenital Generalized, Type 1, also known as congenital generalized lipodystrophy type 1, is related to lipodystrophy, familial partial, type 2 and acquired generalized lipodystrophy, and has symptoms including myalgia An important gene associated with Lipodystrophy, Congenital Generalized, Type 1 is AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2), and among its related pathways/superpathways are Glucose / Energy Metabolism and Adipogenesis. The drugs Empagliflozin and Hypoglycemic Agents have been mentioned in the context of this disorder. Affiliated tissues include bone and liver, and related phenotypes are cardiomyopathy and hepatomegaly
Related ID：
Basic Information
Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
Medical Symptom
#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
Gene & Mutation
#
Gene
Function
Score
Mutations
Related Drugs
Name
CAS Number
Status
Phase
Disease Model
Category
Name
MGI
Related Gene
Strain of Origin
Publications
References Literature
Title
PMID
Journal
Year
IF
